IHS Chemical Week

People & Business :: Earnings/Finance

Evogene files for IPO worth up to $60 million

12:10 PM MDT | September 24, 2013 | Rebecca Coons

Evogene (Rehovot, Israel), a plant genomics firm in which Monsanto and Bayer hold 8.7% and 4.6% stakes, respectively, announced today that it has filed a registration statement with the United States SEC for a proposed initial public offering worth up to $60 million. Additional terms have not been disclosed. According to an F-1 filing, Evogene intends to use approximately half of the proceeds to expedite the commercialization of seed traits and expand its seed traits project portfolio into new traits and crops. The remaining funds will be used to establish...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa